Will We Have Access to Healthcare? Escalating Burden of Chronic Disease Hospitalizations: Evidence From Routine Hospital Data
Author(s)
Bukanova-Berend D1, Campbell-James T2, Vogel J3
1University of St. Gallen, St. Gallen, SG, Switzerland, 2AstraZeneca AG, Medical Affairs, Baar, ZG, Switzerland, 3University of St. Gallen, St. Gallen, Switzerland
Presentation Documents
OBJECTIVES: This study quantifies PAHs and associated resources, measured in bed capacities and healthcare expenditures in Switzerland between 2012 and 2032 for two respiratory and two cardiovascular diseases, and type 2 diabetes. We aim to evaluate health and financial burden on the healthcare system and identify factors driving the change in PAHs.
METHODS: We developed a matching algorithm to identify PAHs in hospital routine data from the Swiss Federal Statistical Office. We derived the number of occupied hospital beds and expenditures. Regression analysis was employed to identify factors underlying changes in PAHs.
RESULTS: In 2018, PAH cases in Switzerland accounted for 40.2 k, projected to double by 2032. The need for PAH-related beds was 1,300 in 2018 and is expected to surpass 1,700 beds by 2032. The financial burden of PAHs was 430M Swiss francs (CHF) in 2022 and projected to exceed 590M CHF by 2032. Regression analysis indicates demographic change as a main driver of rising PAHs.
CONCLUSIONS: Our findings indicate a significant increase in PAHs and associated resources, likely leading to unmet demand by supply in the near future, and resulting in worsened quality and access to healthcare services. Effective primary care and improved patient self-management are crucial for managing chronic conditions and reducing PAHs. Our study provides a detailed financial analysis of PAHs, offering valuable insights for healthcare stakeholders.
Conference/Value in Health Info
Value in Health, Volume 27, Issue 12, S2 (December 2024)
Code
HPR210
Topic
Health Policy & Regulatory
Topic Subcategory
Public Spending & National Health Expenditures, Reimbursement & Access Policy
Disease
Cardiovascular Disorders (including MI, Stroke, Circulatory), Diabetes/Endocrine/Metabolic Disorders (including obesity), No Additional Disease & Conditions/Specialized Treatment Areas, Respiratory-Related Disorders (Allergy, Asthma, Smoking, Other Respiratory)